Carl Fredrik Warfvinge
1 – 5 of 9
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Averaging of absorbed doses : How matter matters
(
- Contribution to journal › Article
- 2022
-
Mark
Dosimetric quantities of neuroendocrine tumors over treatment cycles with 177Lu-DOTA-TATE
(
- Contribution to journal › Article
-
Mark
Effect of primary tumour resection without curative intent in patients with metastatic neuroendocrine tumours of the small intestine and right colon : meta-analysis
(
- Contribution to journal › Article
-
Mark
Long-term survival of metastatic small intestine neuroendocrine tumors : a meta-analysis
(
- Contribution to journal › Article
-
Mark
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients
(
- Contribution to journal › Article